Journal profile
Journal of Cancer and Allied Specialties
ISSN 2411-989X · Shaukat Khanum Memorial Cancer Hospital & Research Centre · Pakistan
Journal of Cancer and Allied Specialties: diamond open access (no APC); no APC; review about 12 weeks (community reports); 10 articles in 2025.
Scope
Aims, scope and focus
Journal of Cancer and Allied Specialties is published by Shaukat Khanum Memorial Cancer Hospital & Research Centre. By OpenAlex counts of its recent articles, its largest topics are Breast Lesions and Carcinomas, Lymphoma Diagnosis and Treatment and Sarcoma Diagnosis and Treatment, together about 23.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Cancer and Allied Specialties is an open-access journal dedicated to disseminating high-quality scholarly work in the field of oncology. The journal welcomes submissions of original research articles, comprehensive reviews, and insightful clinical case reports that contribute to the evolving understanding and treatment of cancer.The Journal of Cancer and Allied Specialties serves as a platform for researchers, clinicians, and healthcare professionals to share findings across a broad spectrum of oncological disciplines, encompassing both experimental and clinical investigations. Key areas of focus include, but are not limited to:Adjunct Supportive Care and Palliative Care: Strategies addressing the holistic needs of cancer patients, providing symptom management and supportive care to enhance their quality of life during treatment.Cancer Biology: Investigations into the biological mechanisms underlying cancer and tumor development.Chemotherapy: Research into the mechanisms of action, efficacy, and toxicity of chemotherapeutic agents.Cancer Diagnostics: Advancements in diagnostic modalities, including imaging techniques, molecular diagnostics, and liquid biopsies, for early detection and personalized oncological treatment strategies.Cancer Epidemiology: Studies examining the incidence, distribution, and risk factors associated with various cancers.Cancer Epigenomics and Genomics: Research into the role of epigenetic modifications and genetic alterations in cancer development and therapeutic responses.Cancer Immunology and Immunotherapy: Studies focused on the immune system's role in cancer and the development of immunotherapeutic approaches.Radiotherapy: Research on advanced radiotherapeutic techniques and their effectiveness in cancer treatment.Surgical Oncology: Advancements in surgical techniques and approaches for cancer resection and management.Transplant Oncology: Exploration of transplantation's role in treating hematological malignancies and other cancers.
From the journal's Aims & Scope
Editor-in-chief Mohammad JahanzebPublisher website
Editorial board by country: none in mainland China; most named Pakistan 7, United States 2 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Lesions and CarcinomasMedicine8.6%
- Lymphoma Diagnosis and TreatmentMedicine7.3%
- Sarcoma Diagnosis and TreatmentMedicine7.3%
- Head and Neck Cancer StudiesMedicine6%
- Medical Imaging Techniques and ApplicationsMedicine6%
- Pancreatic and Hepatic Oncology ResearchMedicine5.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.3%
- Ovarian cancer diagnosis and treatmentMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 6OpenAlex ·
- i10-index
- 3OpenAlex ·
- 2-year mean citedness
- 0.52OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 207 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 42 |
| 2025 | 10 | 10 | 53 |
| 2024 | 16 | 16 | 30 |
| 2023 | 9 | 9 | 15 |
| 2022 | 11 | 11 | 18 |
| 2021 | 6 | 6 | 16 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- case reportinsightful clinical case reportsLength not stated
- original researchoriginal research articlesLength not stated
- reviewcomprehensive reviewsLength not stated
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright 2026 © Paradigm. All rights reserved.
Currency:EUR €USD $GBP £ Terms of servicePrivacy policyEthical policiesAccessibility
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Shaukat Khanum Memorial Cancer Hospital & Research Centre
- Country or region
- Pakistan
- Language
- English
- ISSN
- 2411-989X
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Cancer and Allied Specialties
How long does peer review take at Journal of Cancer and Allied Specialties?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Cancer and Allied Specialties based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Pakistan (7) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cancer and Allied Specialties?
According to LetPub and DOAJ records, Journal of Cancer and Allied Specialties is indexed in DOAJ.
Is Journal of Cancer and Allied Specialties open access, and what is the APC?
Journal of Cancer and Allied Specialties is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .